Cost-Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study
José Seijas-Amigo, M. José Mauriz-Montero, Pedro Suarez-Artime, Mónica Gayoso-Rey, Francisco Reyes-Santías, Ana Estany-Gestal, Antonia Casas-Martínez, Lara González-Freire, Ana Rodriguez-Vazquez, Natalia Pérez-Rodriguez, Laura Villaverde-Piñeiro, Concepción Castro-Rubinos, Esther Espino-Faisán, Octavio Cordova-Arevalo, Moisés Rodríguez-Mañero, Alberto Cordero, José R. González-Juanatey, e Investigadores MEMOGAL
medRxiv 2023.12.05.23299557; doi: https://doi.org/10.1101/2023.12.05.23299557